OSAIC HOLDINGS, INC. - TALIS BIOMEDICAL CORP ownership

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q2 2023$751
-2.0%
1,5640.0%0.00%
Q1 2023$7661,5640.0%0.00%
Q4 2022$0
-100.0%
1,564
-21.8%
0.00%
Q3 2022$2,0000.0%2,0000.0%0.00%
Q2 2022$2,0000.0%2,0000.0%0.00%
Q1 2022$2,000
-77.8%
2,000
-7.0%
0.00%
Q4 2021$9,000
-30.8%
2,1500.0%0.00%
Q3 2021$13,0000.0%2,150
+87.0%
0.00%
Q2 2021$13,000
-13.3%
1,1500.0%0.00%
Q1 2021$15,0001,1500.00%
Other shareholders
TALIS BIOMEDICAL CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Greenlight Capital 2,235,783$1,095,5340.06%
Baker Brothers Advisors 7,624,835$3,736,1690.02%
PRELUDE CAPITAL MANAGEMENT, LLC 223,934$109,7280.01%
ArrowMark Colorado Holdings LLC 478,862$234,6420.00%
WELLS FARGO & COMPANY/MN 167$820.00%
NORTHERN TRUST CORP 27,860$13,6520.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 144,416$70,7630.00%
STATE STREET CORP 49,536$24,2730.00%
MILLENNIUM MANAGEMENT LLC 163,663$800.00%
View complete list of TALIS BIOMEDICAL CORP shareholders